Xu, Changjiang <br/><br/>
Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.  [electronic resource] 

 -  Oncogene  Jun 2005 
 - 4486-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1208656  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticarcinogenic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cyclin D1--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>I-kappa B Kinase<br/>I-kappa B Proteins--drug effects<br/>Isothiocyanates--pharmacology<br/>Male<br/>NF-KappaB Inhibitor alpha<br/>NF-kappa B--drug effects<br/>Phosphorylation<br/>Prostatic Neoplasms--drug therapy<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-bcl-2--drug effects<br/>Sulfoxides<br/>Thiocyanates--pharmacology<br/>Transcription, Genetic<br/>Vascular Endothelial Growth Factor A--drug effects<br/>bcl-X Protein